GlassScriptPhysician profile
Carlos C Emanuel
NPI 1417946773
$6,804.35
in general payments reported to CMS, 2019-2025
36 companies · $615 in 2025
The $615 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,576 · 2020: $457 · 2021: $1,311 · 2022: $1,123 · 2023: $920 · 2024: $802 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,336.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $850.78 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $648.01 | 2019-2024 | |
| Penumbra, INC. | $644.19 | 2019-2025 | Indigo System, Ruby Coil |
| Biotronik INC. | $600.06 | 2019-2020 | |
| Abbott Laboratories | $589.52 | 2020-2025 | Aveir, Xience Skypoint, Mitraclip |
| Boston Scientific Corporation | $561.93 | 2019-2025 | General - Pain Management |
| Janssen Pharmaceuticals, INC | $367.72 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $320.89 | 2021-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $231.75 | 2019-2020 | |
| Pfizer INC. | $215.75 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $203.83 | 2019-2024 | Farxiga |
| Shockwave Medical, INC | $169.21 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.37 | 2021-2025 | Jardiance |
| Viz.Ai, INC. | $146.57 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $128.96 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $124.76 | 2024-2025 | Ffrangio |
| Intuitive Surgical, INC. | $80.93 | 2024 | |
| Sanofi-Aventis U.S. LLC | $78.68 | 2021-2024 | |
| Chiesi USA, INC. | $75.13 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $65.09 | 2023-2024 | Inpefa |
| W. L. Gore & Associates, INC. | $56.00 | 2023-2024 | Gore Cardioform Septal Occluder |
| Kiniksa Pharmaceuticals, LTD. | $52.06 | 2022-2023 | Arcalyst |
| Philips North America LLC | $50.03 | 2021 | |
| Amgen INC. | $49.22 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $46.94 | 2024-2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $41.20 | 2022-2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $40.27 | 2019 | |
| Astellas Pharma US INC | $38.71 | 2019 | |
| Novo Nordisk INC | $36.97 | 2022-2023 | Rybelsus, Ozempic |
| Cvrx, INC. | $33.38 | 2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $28.40 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cardinal Health 200 LLC | $20.50 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $20.35 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $16.30 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $15.39 | 2022 | |
| Cardiovascular Systems INC. | $6.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Emanuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.